TAP
Biosystems, (the new corporate identity of The Automation Partnership), a
leading supplier of innovative automation and consumables for life science
applications, is delighted to announce it is currently working on projects to install
six Cellmate
TM automated cell culture systems in three of the world's leading biopharma
companies, where they will improve reproducibility and throughput of
biotherapeutics manufacturing.
TAP
Biosystems' Cellmate is an established system that automates the processing of
cells in roller bottles and T-flasks. To date over 80 systems have been
installed world-wide. The latest six systems purchased by three international
pharmaceutical companies will be installed to increase the manufacturing capacity
of vaccines and protein-based therapies from adherent cell lines.
The pharmaceutical companies chose to
install Cellmate systems because the automation improves reproducibility, reduces
the risk of contamination and increases productivity. In addition, as Cellmate emulates the manual
handling of roller bottle and T-flask cell culture, taking cell
culturing from the lab to high volume production without process change. The Cellmates come
with software designed to support the validation of the system for compliance
with 21 CFR Part 11 and TAP provides full support for IQ and OQ, which makes integrating the
Cellmates into the GMP facilities at these firms a straightforward task.
Tim
Ward, Cellmate Product Manager at TAP Biosystems commented: "Many bioprocesses continue to
use adherent cell lines that have proven difficult to adapt into stirred tank
bioreactors. In such circumstances Cellmate provides a cost effective scale-up
option and avoids the expense and time of developing and implementing new cell
lines more amenable to suspension culture."
Ward added: "We are
delighted that these three top biopharma companies have taken advantage of the
technical and strategic benefits that using a Cellmate can bring. Their
confidence in this technology is a great endorsement of the Cellmate as an
unrivalled method for cost-effective and reproducible manufacturing of specific types of vaccines, biotherapeutics
and cell therapies."
For further information visit
www.tapbiosystems.com
Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!
Request your free copies HERE
Popular this Month
Top 10 most popular articles this month
Today's Picks
Looking for a Supplier?
Search by company or by product
Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.
Lab Bulletin is published by newleaf marketing communications ltd.